The new article describes in detail the aspects related to the roles and responsibilities of the entities engaged in operations with medical devices.

The Medical Device Authority (MDA), a Malaysian regulatory agency in the sphere of medical devices, has published a guidance document dedicated to the establishment of licenses. The document provides additional clarifications regarding the applicable regulatory requirements, as well as recommendations to be considered by all the parties involved in order to ensure compliance thereto. At the same time, provisions of the guidance are non-binding in their nature, nor are intended to introduce new rules or impose new obligations. The authority also reserves the right to make changes to the guidance and recommendations provided therein, should such changes be reasonably necessary to reflect corresponding changes to the underlying regulations. 

The scope of the guidance covers, inter alia, the aspects related to the types of establishment licenses as set forth under the existing legislation, the application process to be followed in order to obtain a license, as well as the actions to be taken in case of changes that require amendments to an existing license. The document also contains an annex describing in detail the roles and responsibilities of the license holders. 


Business Models

First of all, the document describes various business models based on the nature of the relationship between the entities and highlights the key points associated thereto. 

The first model is a representation based on a Letter of Authorization (LOA). According to the guidance, such a letter could be issued by a foreign medical device manufacturer to a local authorized representative (AR) appointed to represent the manufacturer in Malaysia. An authorized representative or a local manufacturer could also issue an LOA to a distributor, authorizing the latter to place registered medical devices on the country’s market. Authorization could also be granted to an importer.

It is important to mention that all the above mentioned entities are subject to licensing requirements, i.e., should duly obtain the appropriate establishment license in order to be allowed to undertake the respective activity. The approach to be applied with respect to a tendering agent is a bit different – in accordance with the existing legislation, a tendering agent does not require a license. License is also not required for an entity involved in leasing medical devices – for example, to customers or healthcare institutions. 

As further explained by the MDA, a distributor may outsource their activities such as warehousing, storage and handling, and transportation to the supplier of outsourced activities / third party. However, the distributor shall have control over the outsourced activities of the appointed supplier of outsourced activities / third party within their scope of the GDPMD and shall ensure the compliance of all requirements by having in place an established procedure and contractual agreements with the outsource parties. The authority also mentions that the said certification is not mandatory for such third parties, however, they can still apply for it. The information about third parties involved in operations with medical devices should also be duly reflected in the quality manual of the distributor. 

Under the existing regulatory framework, medical device manufacturers are allowed to appoint multiple authorized representatives. These manufacturers will be able to apply for registration and further be involved in supplying the same medical device, provided their activities are compliant with the respective regulatory requirements, and authorization is duly obtained from the initial medical device manufacturer based overseas. 

Letter of Authorization 

In order to assist all the parties involved in ensuring compliance with the applicable regulatory requirements, the guidance also provides a template for a Letter of Authorisation to be used as an example when issuing an LOA as described hereinabove. 

According to the template provided by the MDA, a letter should be printed on the letterhead of the medical device manufacturer and contain the following key elements: 

  • Name of an authorized representative;
  • A clause stating that hereby a foreign medical device manufacturer authorizes an entity based in Malaysia to act as its authorized representative, namely to apply for registration of a medical device and submit any documents associated with the procedure, make statements with respect to the medical device in question, and conduct other actions in accordance with the respective legislation;
  • A statement that the authorization remains valid until the manufacturer will notify the authority about its revocation;
  • An undertaking to provide all necessary support to the distributor/importer they may reasonably need in the course of their activity;
  • Acknowledgment that failure to comply with the applicable regulatory requirements could result in medical device registration being suspended or canceled; and
  • Undertaking to provide the authority with all the information about the medical device in question upon request.

In case of a letter of authorization issued by a foreign medical device manufacturer to a distributor/importer, a scope of authorization should be listed for the distribution/import of a medical device that is already registered under the applicable regulatory framework. A similar approach should be applied in case of an LOA issued by a local medical device manufacturer to a distributor. 

In all cases, a letter of authorization should contain a list of medical devices it covers. 

In summary, the present MDA guidance provides an overview of the responsibilities of the entities involved in operations with medical devices, as well as additional recommendations to be considered in this respect. Apart from this, the document provides the templates of various authorization letters to be issued by foreign or local medical device manufacturers when authorizing a distributor, importer, or authorized representative to act on their behalf. 



How Can RegDesk Help?

RegDesk is a next-generation web-based software for medical device and IVD companies. Our cutting-edge platform uses machine learning to provide regulatory intelligence, application preparation, submission, and approvals management globally. Our clients also have access to our network of over 4000 compliance experts worldwide to obtain verification on critical questions. Applications that normally take 6 months to prepare can now be prepared within 6 days using RegDesk Dash(TM). Global expansion has never been this simple.